Charles River Laboratories International Inc (NYSE:CRL)
| 245.12 Delayed Data As of Jan 27 |  +0.83 / +0.34%Today’s Change | 181.36 Today|||52-Week Range 349.84 | +12.49% Year-to-Date |
Latest CRL News | Press Releases
| EADS & HEALD WEALTH MANAGEMENT Buys 2, Sells 3 in 4th Quarter Jan 27 / GuruFocus News - Paid Partner Content | Charles River (CRL) to Develop RNA-based Therapy With New Pact Jan 19 / Zacks.com - Paid Partner Content |
| Charles River's (CRL) New CDMO Tie-Up to Boost Clinical Trials Jan 20 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 244.29 |
| Today’s open | 242.45 |
| Day’s range | 241.14 - 246.63 |
| Volume | 366,844 |
| Average volume (3 months) | 603,444 |
| Market cap | $12.5B |
Data as of 3:59pm ET, 01/27/2023
Growth & Valuation
| Earnings growth (last year) | +5.74% |
| Earnings growth (this year) | +5.56% |
| Earnings growth (next 5 years) | +11.74% |
| Revenue growth (last year) | +21.08% |
| P/E ratio | 28.8 |
| Price/Sales | 5.36 |
| Price/Book | 4.90 |
Competitors
Data as of 3:59pm ET, 01/27/2023
Financials
| Next reporting date | February 15, 2023 |
| EPS forecast (this quarter) | $2.75 |
| Annual revenue (last year) | $3.5B |
| Annual profit (last year) | $391.0M |
| Net profit margin | 11.04% |
Profile
Sector Commercial Services |
Industry Miscellaneous Commercial Services |
No executives to display |
Corporate headquarters --, -- |
Forecasts
